Sanofi gets green light for first-ever targeted COPD treatment
EU approves drug to treat chronic lung diseaseFirst targeted treatment for COPDDrug expected to generate €20 billion in salesFrench drug maker Sanofi (SAN:EPA) has received European regulatory approval for Dupixent, its asthma...
03 July 2024